Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Chapter 18 - Individual differences in sleep duration and responses to sleep loss

  • from Section 3 - Sleepphysiology and homeostasis
  • Edited by Paul Shaw, Mehdi Tafti, Michael J. Thorpy
  • Book:
    The Genetic Basis of Sleep and Sleep Disorders
    Published online:
    05 November 2013
    Print publication:
    24 October 2013, pp 189-196

  • Summary

    This chapter describes the recent progress on the molecular mechanism of prostaglandin (PG) D2-induced sleep, basic and clinical studies on the roles of PGD2 in physiological sleep regulation, and current and emerging roles of adenosine in regulating sleep. There are two distinct types of PGD synthase (PGDS), one being lipocalin-type PGDS (L-PGDS) and the other, hematopoietic PGDS (H-PGDS). When PGD2 is infused into the subarachnoid space of the basal forebrain of wild-type mice, the region in which DP1 receptors are most abundant, the extracellular adenosine concentration increases in a dose-dependent manner. This increase is absent in DP1 receptor knockout (KO) mice, indicating that the increase in adenosine in the subarachnoid space depends on DP1 receptors. Adenosine deaminase, an enzyme that catabolizes adenosine to inosine, is predominantly localized in the tuberomammilary nucleus (TMN) of the brain.